Skip to main content
. 2020 Jun 7;8(2):285. doi: 10.3390/vaccines8020285

Figure 3.

Figure 3

Oral administration of E. coli O86:B7 induces a significant decrease in the levels of anti-Galα1-3Galβ1-4GlcNAc IgY Abs in A. fumigatus-infected turkeys. The levels of circulating anti-α-Gal IgY Abs to Galα1-3Gal (A) and Galα1-3Galβ1-4GlcNAc (B) were measured by ELISA. Anti-Galα1-3Gal IgY Abs increased in the sera of turkeys treated with E. coli O86:B7 and E. coli BL21. Oral administration of E. coli O86:B7 produces a significant reduction in anti-Galα1-3Galβ1-4GlcNAc IgY Abs when compared with turkeys that were treated or not E. coli BL21. Results shown are means and standard deviation values. Results were compared by One-way ANOVA with Dunnett’s multiple comparison test applied for individual comparisons (* p < 0.05, ** p < 0.001, *** p < 0.0001; ns: not significant, 2 experiments, n = 30 and three technical replicates per sample).